Lypressin
Vasopressin analog for central diabetes insipidus. Synthetic antidiuretic hormone with vasoconstrictive properties for polyuria and polydipsia management in neurohypophyseal disorders.
Lypressin is a synthetic octapeptide analog of arginine vasopressin (AVP), a posterior pituitary hormone essential for water homeostasis. It differs from AVP only at position 8 (lysine instead of arginine), exhibiting potent antidiuretic activity with reduced pressor effects. It is primarily indicated for the treatment of diabetes insipidus (central and nephrogenic) and serves as a critical API for formulations requiring vasopressin receptor V2 selectivity.
| Parameter | Specification |
| CAS | 50-57-7 |
| Molecular Formula | C₄₆H₆₅N₁₃O₁₂S₂ |
| Molecular Weight | 1056.22 g/mol |
| Category | Cardiovascular |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Central diabetes insipidus, antidiuresis, vasopressin deficiency |
| CAS | 50-57-7 |
|---|---|
| Applications | Antidiuretic Hormone Analog, Diabetes Insipidus (Central and Nephrogenic), Water Balance Disorders |
Related products
-
Orforglipron
CAS: 2212020-52-3Applications: obesity management, Oral GLP-1 Development, Type 2 diabetes -
Liraglutide
CAS: 204656-20-2Applications: cardiovascular risk reduction, GLP-1, obesity management -
-
Degarelix
CAS: 214766-78-6Applications: Advanced Prostate Cancer, Hormone-dependent Tumors, Testosterone Suppression